1. Home
  2. SNOA vs VSME Comparison

SNOA vs VSME Comparison

Compare SNOA & VSME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • VSME
  • Stock Information
  • Founded
  • SNOA 1999
  • VSME 2013
  • Country
  • SNOA United States
  • VSME Hong Kong
  • Employees
  • SNOA N/A
  • VSME N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • VSME
  • Sector
  • SNOA Health Care
  • VSME
  • Exchange
  • SNOA Nasdaq
  • VSME Nasdaq
  • Market Cap
  • SNOA 4.6M
  • VSME 4.2M
  • IPO Year
  • SNOA 2007
  • VSME 2023
  • Fundamental
  • Price
  • SNOA $2.56
  • VSME $1.16
  • Analyst Decision
  • SNOA
  • VSME
  • Analyst Count
  • SNOA 0
  • VSME 0
  • Target Price
  • SNOA N/A
  • VSME N/A
  • AVG Volume (30 Days)
  • SNOA 97.7K
  • VSME 476.4K
  • Earning Date
  • SNOA 11-07-2024
  • VSME 11-26-2024
  • Dividend Yield
  • SNOA N/A
  • VSME N/A
  • EPS Growth
  • SNOA N/A
  • VSME N/A
  • EPS
  • SNOA N/A
  • VSME N/A
  • Revenue
  • SNOA $13,547,000.00
  • VSME $7,991,103.00
  • Revenue This Year
  • SNOA $36.00
  • VSME N/A
  • Revenue Next Year
  • SNOA $25.26
  • VSME N/A
  • P/E Ratio
  • SNOA N/A
  • VSME N/A
  • Revenue Growth
  • SNOA 11.81
  • VSME N/A
  • 52 Week Low
  • SNOA $2.52
  • VSME $0.65
  • 52 Week High
  • SNOA $9.40
  • VSME $6.26
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 39.95
  • VSME 44.45
  • Support Level
  • SNOA $2.76
  • VSME $1.10
  • Resistance Level
  • SNOA $2.84
  • VSME $1.62
  • Average True Range (ATR)
  • SNOA 0.21
  • VSME 0.21
  • MACD
  • SNOA -0.01
  • VSME -0.05
  • Stochastic Oscillator
  • SNOA 0.01
  • VSME 23.33

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a global network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fanbases on social media platforms. The company's business provides value to two major business stakeholders: Creators and Brands. Its Value to Creators: It empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content. Its Value to Brands: the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content strategy and budget and recommending specific Creators.

Share on Social Networks: